ArticleJournal of the American Heart Association2026
Association Between Hemodynamic Parameters and Gut Microbiota in Fontan Circulation: A Cross-Sectional Study.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Fontan operation results in chronic hemodynamic alterations, including central venous hypertension, which may contribute to gut dysbiosis. This study aimed to compare gut microbiota profiles between Fontan patients and age- and sex-matched healthy controls and to examine how catheter-measured hemodynamic and liver-related parameters relate to microbial alterations.
methodsThis cross-sectional study enrolled 23 Fontan patients and 23 matched controls. Fontan patients underwent cardiovascular assessments, and stool samples were collected from all participants. Gut microbiota profiles were analyzed using 16S rRNA gene sequencing.
resultsCompared with controls, Fontan patients exhibited distinct gut dysbiosis, with lower evenness and significant shifts in beta-diversity. Fontan patients had higher relative abundances of inflammation-associated taxa and lower abundances of short-chain fatty acid-producing or commensal genera. Higher catheter-measured pulmonary and Fontan-circuit pressures and greater transpulmonary gradients were associated with lower microbial diversity and depletion of several beneficial taxa. In contrast, better liver status-reflected by higher serum albumin-coincided with more favorable microbial profiles.
conclusionsFontan patients show a characteristic pattern of gut microbiota disruption that parallels their hemodynamic and hepatic burden. Treating Fontan-related pressures as continuous variables revealed graded associations among circulatory congestion, liver involvement, and gut dysbiosis, supporting a hemodynamic-gut-liver axis in Fontan physiology. Specific bacteria may serve as potential microbial biomarkers for identifying patients at higher risk and for guiding therapeutic interventions aimed at improving clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.